Pamir Ozan

Pamir Ozan is listed in filings as Chief Financial Officer at Niagen Bioscience Inc. This profile follows SEC Form 4 activity through Feb 24, 2026, including purchase activity. Recent filings connect the profile to Niagen Bioscience Inc (NAGE) and ChromaDex Corporation (CDXC). The current snapshot covers public activity from Oct 23, 2024 to Feb 24, 2026. Reported amounts are shown as $306.9K to $15.2K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.